Search results
Results From The WOW.Com Content Network
The more important question is: Why have Inovio's shares fallen for several weeks now?
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
Before you buy stock in Inovio Pharmaceuticals, consider this: ... dropping from $37.3 million in the second quarter of 2023 to $33.3 million in the second quarter of 2024, an almost 11% decrease. ...
Investors are not impressed with the biotech's latest plan to raise cash.
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Inovio Pharmaceuticals wasn’t one of them. The 10 stocks that ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading.
For premium support please call: 800-290-4726 more ways to reach us